Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse1
暂无分享,去创建一个
Giuseppe Penna | L. Adorini | G. Penna | S. Amuchastegui | C. Cossetti | Francesca Aquilano | R. Mariani | B. Fibbi | Benedetta Fibbi | Susana Amuchastegui | Chiara Cossetti | Francesca Aquilano | Luciano Adorini | Roberto Mariani | Nadia Giarratana | Elena De Carli | N. Giarratana | E. De Carli | Nadia Giarratana
[1] S. Senju,et al. Identification of naturally processed helper T-cell epitopes from prostate-specific membrane antigen using peptide-based in vitro stimulation. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[2] H. Kikutani,et al. The murine autoimmune diabetes model: NOD and related strains. , 1992, Advances in immunology.
[3] R. Henderson,et al. Identification of Naturally Processed CD4 T Cell Epitopes from the Prostate-Specific Antigen Kallikrein 4 Using Peptide-Based In Vitro Stimulation1 , 2002, The Journal of Immunology.
[4] Maccioni,et al. Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis , 1998, Clinical and experimental immunology.
[5] Zhen Xiao,et al. Identification of MHC class II-restricted T-cell epitopes in prostate-specific membrane antigen. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[6] N. Ilhan,et al. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome , 2001, International journal of urology : official journal of the Japanese Urological Association.
[7] R. Alexander,et al. Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins. , 1997, Urology.
[8] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[9] Mark S. Anderson,et al. The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.
[10] P. Yarnold,et al. IL-1β AND TNF-α IN PROSTATIC SECRETIONS ARE INDICATORS IN THE EVALUATION OF MEN WITH CHRONIC PROSTATITIS , 2000 .
[11] Bhagirath Singh,et al. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. , 1997, Immunity.
[12] L. True,et al. Identification of rat prostatic steroid-binding protein as a target antigen of experimental autoimmune prostatitis: implications for prostate cancer therapy. , 1997, Journal of immunology.
[13] A. Shafik. Re: Demographic and clinical characteristics of men with chronic prostatitis: the National Institutes of Health Chronic Prostatitis Cohort study. , 2002, The Journal of urology.
[14] Vladimir Brusic,et al. A Peptide-binding Motif for I-Ag7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice , 1997, The Journal of experimental medicine.
[15] A. Doble,et al. Autoimmune T cell responses to seminal plasma in chronic pelvic pain syndrome (CPPS) , 2002, Clinical and experimental immunology.
[16] D. McNeel,et al. Identification of Antigen-Specific IgG in Sera from Patients with Chronic Prostatitis , 2004, Journal of Clinical Immunology.
[17] Y. Nishizuka,et al. Experimental autoimmune prostatitis after neonatal thymectomy in the mouse. , 1985, Clinical and experimental immunology.
[18] M. Depiante-Depaoli,et al. Experimental Autoimmune Damage to Rat Male Accessory Glands (MAG) * , 1981 .
[19] M. Resnick,et al. Experimental rodent models of prostatitis: limitations and potential , 2007, Prostate Cancer and Prostatic Diseases.
[20] P. Ohashi,et al. Making and breaking tolerance. , 2002, Current opinion in immunology.
[21] A. Isacchi,et al. Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes , 2000, The Journal of Immunology.
[22] M. Pontari,et al. Theories of prostatitis etiology , 2002, Current Urology Reports.
[23] K. Itoh,et al. Identification of Peptide Vaccine Candidates for Prostate Cancer Patients with HLA-A3 Supertype Alleles , 2005, Clinical Cancer Research.
[24] J. Cabaniols,et al. Tolerance to a self-protein involves its immunodominant but does not involve its subdominant determinants. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[25] J. Gustafsson,et al. Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Takeuchi,et al. Tissue-specific suppressor T cells involved in self-tolerance are activated extrathymically by self-antigens. , 1994, Immunology.
[27] J. Krieger,et al. NIH consensus definition and classification of prostatitis. , 1999, JAMA.
[28] M. Pontari,et al. Mechanisms in prostatitis/chronic pelvic pain syndrome. , 2008, The Journal of urology.
[29] M. Parker,et al. Organization and Expression of Genes Encoding Prostatic Steroid Binding Protein , 1984, Annals of the New York Academy of Sciences.
[30] R. Alexander,et al. Identification of HLA-DRB1*1501–Restricted T-cell Epitopes from Prostate-Specific Antigen , 2005, Clinical Cancer Research.
[31] R. Shattock,et al. Interleukin‐8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis , 2006, BJU international.
[32] A. Schaeffer,et al. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. , 2000, Urology.
[33] A. Reiss,et al. Syndrome , 1990, Biological Psychiatry.
[34] M. Carini,et al. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. , 2007, European urology.
[35] W. Frankel,et al. NOR/Lt Mice: MHC-Matched Diabetes-Resistant Control Strain for NOD Mice , 1992, Diabetes.
[36] M. Barry,et al. How common is prostatitis? A national survey of physician visits. , 1998, The Journal of urology.
[37] P. Humphrey,et al. Development of a mouse model for nonbacterial prostatitis. , 1994, The Journal of urology.
[38] Lawrence Steinman,et al. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell–mediated tissue damage , 2007, Nature Medicine.
[39] L. Adorini,et al. Understanding autoimmune diabetes: insights from mouse models. , 2002, Trends in molecular medicine.
[40] E. Sercarz,et al. Understanding crypticity is the key to revealing the pathogenesis of autoimmunity. , 2005, Trends in immunology.
[41] R. Berger. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. , 2005, The Journal of urology.
[42] V. Rivero,et al. Prostatein or steroid binding protein (PSBP) induces experimental autoimmune prostatitis (EAP) in NOD mice. , 2002, Clinical immunology.
[43] J. Hebel,et al. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome. , 1998, Urology.
[44] M. Pontari,et al. Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. , 2002, The Journal of urology.
[45] V. Rivero,et al. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. , 2005, Clinical immunology.
[46] L. Adorini,et al. IL-12 Administration Accelerates Autoimmune Diabetes in Both Wild-Type and IFN-γ-Deficient Nonobese Diabetic Mice, Revealing Pathogenic and Protective Effects of IL-12-Induced IFN-γ1 , 2003, The Journal of Immunology.
[47] J. Krieger,et al. Epidemiology of prostatitis: new evidence for a world-wide problem , 2003, World Journal of Urology.
[48] V. Rivero,et al. Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). , 1998, Journal of autoimmunity.
[49] Corman.,et al. Recognition of prostate‐specific antigenic peptide determinants by human CD4 and CD8 T cells , 1998, Clinical and experimental immunology.
[50] A. Tolcher,et al. Management of high risk metastatic prostate cancer: the case for novel therapies. , 2006, The Journal of urology.
[51] Y. Nishizuka,et al. Self tolerance and localized autoimmunity. Mouse models of autoimmune disease that suggest tissue-specific suppressor T cells are involved in self tolerance , 1987, The Journal of experimental medicine.
[52] D. McNeel,et al. Identification of T helper epitopes from prostatic acid phosphatase. , 2001, Cancer research.
[53] M. Depiante-Depaoli,et al. Experimental Autoimmune Damage to Rat Male Accessory Glands. II. T Cell Requirement in Adoptive Transfer of Specific Tissue Damage , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.
[54] M. Depiante-Depaoli,et al. Experimental autoimmunity to rat male accessory glands (MAG): circulating antibodies, immunoglobulins bound to target glands, and immunoglobulins-secreting cells. , 1985, American journal of reproductive immunology and microbiology : AJRIM.
[55] C. Doglioni,et al. Treatment of Experimental Autoimmune Prostatitis in Nonobese Diabetic Mice by the Vitamin D Receptor Agonist Elocalcitol1 , 2006, The Journal of Immunology.
[56] R. Alexander,et al. PSA is a candidate self‐antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome , 2000, The Prostate.
[57] M. Depiante-Depaoli,et al. Experimental Autoimmune Damage to Rat Male Accessory Glands. I. Transfer of Autoimmune Response by Spleen Cells , 1984, American journal of reproductive immunology : AJRI : official journal of the American Society for the Immunology of Reproduction and the International Coordination Committee for Immunology of Reproduction.